CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Open-market sale 10% owner sold 1,142,273 shares at an average $11.46 ($13,084,796)
- 4 Open-market sale 10% owner sold 748,230 shares at an average $11.30 ($8,454,808)
- 4 Open-market sale President & COO sold 1,000,000 shares at an average $11.15 ($11,154,942)
- 4 Shares withheld for taxes CFO gave up 1,653 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 3,487 shares (to pay taxes)
- 4 Planned sale President & COO sold 100,000 shares at $10.95 ($1,095,000)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 898,959 shares at an average $11.27 ($10,129,810)
- 4 Shares withheld for taxes CFO gave up 1,653 shares (to pay taxes)
- 4 Grant or award CFO acquired 141,464 shares (grant or award)
- 4 Planned sale President & COO sold 100,000 shares at $10.22 ($1,022,000)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Grant or award Director acquired 1,847 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 276 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 64 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 1,653 shares (to pay taxes)
- 4 Planned sale President & COO sold 750,000 shares at an average $10.92 ($8,190,725)
- 4 Grant or award Chief Accounting Officer acquired 112,255 shares (grant or award)
- 4 Shares withheld for taxes CFO gave up 1,504 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
Page 8 of 26 · 511 filings